GHP Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Sell
13,009
-4,583
-26% -$401K 0.04% 275
2026
Q1
$1.5M Buy
17,592
+755
+4% +$67.3K 0.06% 250
2025
Q4
$1.33M Sell
16,837
-718
-4% -$56.3K 0.05% 257
2025
Q3
$1.4M Sell
17,555
-974
-5% -$83.1K 0.06% 248
2025
Q2
$1.68M Sell
18,529
-1,436
-7% -$131K 0.07% 236
2025
Q1
$1.87M Sell
19,965
-1,268
-6% -$114K 0.09% 228
2024
Q4
$1.93M Sell
21,233
-98
-0.5% -$9.35K 0.09% 229
2024
Q3
$2.21M Sell
21,331
-1,430
-6% -$146K 0.1% 220
2024
Q2
$2.21M Sell
22,761
-182
-0.8% -$16.8K 0.11% 213
2024
Q1
$2.07M Sell
22,943
-8,246
-26% -$699K 0.1% 222
2023
Q4
$2.49M Sell
31,189
-13,986
-31% -$1.05M 0.13% 205
2023
Q3
$3.21M Sell
45,175
-2,098
-4% -$157K 0.19% 163
2023
Q2
$3.64M Sell
47,273
-2,215
-4% -$171K 0.21% 158
2023
Q1
$3.72M Sell
49,488
-3,296
-6% -$245K 0.24% 150
2022
Q4
$4.16M Buy
52,784
+963
+2% +$72.2K 0.28% 129
2022
Q3
$3.64M Sell
51,821
-56
-0.1% -$4.39K 0.28% 130
2022
Q2
$4.16M Buy
51,877
+651
+1% +$50.9K 0.31% 122
2022
Q1
$3.88M Buy
51,226
+905
+2% +$71.7K 0.26% 139
2021
Q4
$4.29M Buy
50,321
+221
+0.4% +$17.3K 0.3% 116
2021
Q3
$3.79M Buy
50,100
+619
+1% +$49.2K 0.3% 119
2021
Q2
$4.03M Buy
49,481
+6,317
+15% +$517K 0.32% 115
2021
Q1
$3.4M Buy
43,164
+3,055
+8% +$239K 0.3% 123
2020
Q4
$3.43M Buy
40,109
+1,457
+4% +$120K 0.33% 114
2020
Q3
$2.98M Buy
38,652
+1,833
+5% +$140K 0.34% 107
2020
Q2
$2.7M Buy
36,819
+408
+1% +$29K 0.33% 105
2020
Q1
$2.42M Sell
36,411
-608
-2% -$42.9K 0.36% 93
2019
Q4
$2.55M Buy
37,019
+125
+0.3% +$8.52K 0.27% 114
2019
Q3
$2.71M Sell
36,894
-2,306
-6% -$167K 0.34% 97
2019
Q2
$2.81M Sell
39,200
-1,057
-3% -$75K 0.34% 101
2019
Q1
$2.76M Sell
40,257
-425
-1% -$27.5K 0.36% 95
2018
Q4
$2.42M Sell
40,682
-2,950
-7% -$185K 0.36% 92
2018
Q3
$2.92M Sell
43,632
-523
-1% -$34.8K 0.39% 84
2018
Q2
$2.86M Buy
44,155
+248
+0.6% +$16.2K 0.4% 77
2018
Q1
$3.15M Sell
43,907
-345
-0.8% -$24.8K 0.45% 65
2017
Q4
$3.34M Sell
44,252
-290
-0.7% -$21.2K 0.47% 61
2017
Q3
$3.25M Sell
44,542
-514
-1% -$37K 0.49% 58
2017
Q2
$3.34M Sell
45,056
-3,761
-8% -$279K 0.53% 52
2017
Q1
$3.57M Buy
48,817
+2,054
+4% +$144K 0.61% 37
2016
Q4
$3.06M Buy
46,763
+6,636
+17% +$455K 0.57% 44
2016
Q3
$2.98M Buy
40,127
+439
+1% +$32.5K 0.61% 35
2016
Q2
$2.9M Buy
39,688
+22
+0.1% +$1.57K 0.63% 36
2016
Q1
$2.8M Sell
39,666
-145
-0.4% -$9.65K 0.63% 33
2015
Q4
$2.65M Sell
39,811
-83
-0.2% -$5.52K 0.64% 33
2015
Q3
$2.53M Buy
39,894
+665
+2% +$43.4K 0.65% 32
2015
Q2
$2.63M Buy
39,229
+2,626
+7% +$178K 0.65% 30
2015
Q1
$2.54M Buy
36,603
+1,073
+3% +$74.2K 0.66% 26
2014
Q4
$2.46M Buy
35,530
+623
+2% +$42.1K 0.68% 27
2014
Q3
$2.28M Buy
34,907
+1,103
+3% +$72.7K 0.67% 29
2014
Q2
$2.31M Buy
33,804
+1,521
+5% +$102K 0.68% 28
2014
Q1
$2.09M Buy
32,283
+381
+1% +$24K 0.67% 28
2013
Q4
$2.08M Buy
31,902
+1,011
+3% +$64.7K 0.69% 25
2013
Q3
$1.83M Buy
30,891
+406
+1% +$24.1K 0.67% 27
2013
Q2
$1.75M Buy
+30,485
New +$1.81M 0.7% 27

Other funds holding CL

GHP Investment Advisors's CL Position: Q2 2026 in Review

GHP Investment Advisors reduced its Colgate-Palmolive (CL) stake by 26% in Q2 2026, selling an estimated $401K and leaving 13,009 shares worth $1.19M. The position accounts for 0.04% of the portfolio, ranked #275.

GHP Investment Advisors first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.29M in Q4 2021. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • GHP Investment Advisors held 13,009 shares of Colgate-Palmolive worth $1.19M as of Q2 2026.
  • GHP Investment Advisors sold 4,583 Colgate-Palmolive shares in Q2 2026, an estimated $401K.
  • Colgate-Palmolive made up 0.04% of GHP Investment Advisors's portfolio in Q2 2026, its #275 holding.
  • GHP Investment Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • GHP Investment Advisors's Colgate-Palmolive position peaked at $4.29M in Q4 2021.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.